Drug Policy in the UK: Why Decriminalisation and Drug Consumption Rooms Matter

In 2019, drug-related deaths in the UK rose to their highest recorded level, with 4,393 deaths and Scotland becoming the drug death capital of the world. The House of Commons Health and Social Care Committee described the situation as a “public health emergency” and called for decriminalisation and the introduction of drug consumption rooms. This article explores the impact of current criminal policy and the potential benefits of decriminalisation, focusing specifically on drug consumption rooms as a case study.

The current system

The United Nations Office on Drugs and Crime has acknowledged the harms associated with punitive drug policies and has increasingly shifted its rhetoric towards harm reduction. However, this shift is not reflected in the UK. The UK continues to rely on a hard-line criminal justice approach, underpinned by the Misuse of Drugs Act 1971 and strategies that focus heavily on recovery through criminal justice intervention. Examples include placing drug workers in police custody suites and introducing court-ordered treatment for offenders under probation supervision.

Although these measures aim to channel people into treatment, questions remain about their effectiveness and ethical implications. The 2010 Drug Strategy sought to target “problem drug users” and reduce offending by expanding treatment capacity. While this appears beneficial on the surface, the reality is that all drug users are criminalised, regardless of the level of harm associated with their use. Criminalisation brings stigma, social exclusion and long-term consequences that often outweigh the harms of drug use itself.

Compulsory and quasi-compulsory treatment are also significantly less effective than treatment entered voluntarily. This makes current policy both ineffective and harmful. Harm reduction measures such as take-home naloxone and needle exchange programmes exist, but a criminal justice framework limits their reach and impact.

Recovery is not an ignoble goal, but for many people it is unrealistic. Drug dependence is a chronic relapsing condition. Societies that focus primarily on abstinence set people up for failure. Evidence-based approaches have been sidelined in favour of policies that assume total abstinence is achievable for all, exacerbating harms for users, families and communities.

Harms caused by criminalisation

The Home Office has concluded that there is no evidence that tougher sanctions deter drug use. Instead, criminalisation creates additional harms. Imprisonment and criminal records impose long-term social and economic consequences. For many infrequent or non-problematic users, the negative impact of a criminal record is far greater than the impact of continued occasional drug use. A fifth of people who use drugs spend much of their lives cycling through the criminal justice system, with serious consequences for health, employment and housing.

Criminalisation also intensifies stigma. Labelling individuals as criminals shapes how people perceive and treat them. Drug use is often viewed as a sign of moral failure or dissolute behaviour, reinforcing discrimination.

These impacts fall disproportionately on vulnerable groups. Problematic drug use often develops in the context of Adverse Childhood Experiences and socioeconomic deprivation. Areas with concentrated poverty experience higher levels of drug use and have fewer resources to respond. They also tend to have higher rates of stop and search and other proactive policing practices, which increase the impact of criminalisation on disadvantaged communities. Racial disparities are stark. Black people are 4.2 times more likely to be stopped and searched and more likely to be charged than white people, despite lower rates of drug use among BAME groups.

By contrast, decriminalisation reduces the number of people entering the criminal justice system, with particularly positive effects for minority groups and young people. It protects individuals from the scarring effects of criminalisation, reduces gang influence and improves police community relations. The Durham Checkpoint Programme demonstrates this by reducing reoffending and offering people an alternative to prosecution.

Criminal justice approaches also create public health risks. Fear of arrest pushes people into unhygienic practices such as needle sharing and rushed injections. It also makes it harder to provide medical support, as people avoid services due to fear of judgment or legal consequences. Portugal’s experience illustrates the benefits of decriminalisation. Between 2001 and 2012, HIV infections from needle sharing fell from around 1,016 to 56, and drug-related deaths fell from around 80 to 16.

These harms are likely to worsen. Local authorities have faced ongoing cuts to public health budgets, which fund drug treatment services. The public health workforce could significantly mitigate gaps in provision, but training and support are not being offered. Budget cuts following the pandemic will likely exacerbate this. Without top-down policy change, improvements are unlikely.